PARP inhibitors in ovarian cancer: What are the next steps?

Date 10 October 2016
Event ESMO 2016 Congress
Session Advances in targeted therapy in gynaecological cancers
Topics Anti-Cancer Agents & Biologic Therapy
Ovarian Cancer
Presenter Jonathan Ledermann
Authors J.A. Ledermann
  • Cancer Research Uk And Ucl Cancer Trials Centre, University College London Cancer Institute, WC1E6BT - London/GB